Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
Microb Biotechnol ; 15(7): 1984-1994, 2022 07.
Article in English | MEDLINE | ID: covidwho-1794785

ABSTRACT

Infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can trigger excessive interleukin (IL)-6 signalling, leading to a myriad of biological effects including a cytokine storm that contributes to multiple organ failure in severe coronavirus disease 2019 (COVID-19). Using a mouse model, we demonstrated that nasal inoculation of nucleocapsid phosphoprotein (NPP) of SARS-CoV-2 increased IL-6 content in bronchoalveolar lavage fluid (BALF). Nasal administration of liquid coco-caprylate/caprate (LCC) onto Staphylococcus epidermidis (S. epidermidis)-colonized mice significantly attenuated NPP-induced IL-6. Furthermore, S. epidermidis-mediated LCC fermentation to generate electricity and butyric acid that promoted bacterial colonization and activated free fatty acid receptor 2 (Ffar2) respectively. Inhibition of Ffar2 impeded the effect of S. epidermidis plus LCC on the reduction of NPP-induced IL-6. Collectively, these results suggest that nasal S. epidermidis is part of the first line of defence in ameliorating a cytokine storm induced by airway infection of SARS-CoV-2.


Subject(s)
COVID-19 , Cytokine Release Syndrome , Staphylococcus epidermidis , Animals , COVID-19/immunology , COVID-19/prevention & control , Coronavirus Nucleocapsid Proteins , Cytokine Release Syndrome/prevention & control , Interleukin-6 , Lung , Mice , Nasal Cavity/microbiology , Phosphoproteins , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL